Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
145studies shown
Showing 1-12 of 145
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In Switzerland
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Behavioral study icon
RecruitingISRCTN76324634

Adherence therapy for schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Switzerland.

In Switzerland
SchizophreniaOtherOver 18 Years
Countries
United Kingdom, Switzerland
Sponsor
Clinic of Psychiatry and Psychotherapy Bethel (Germany)
Condition
Schizophrenia
Drug study icon
RecruitingNCT06927076

Antidepressant Response of DMT Masked With Propofol

This study is recruiting. It focuses on depression and currently lists participation information in Switzerland.

In Switzerland
DepressionOtherOver 21 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Depression
Other study type icon
RecruitingNCT05842330

Benefits of ADHD Treatment in Detained People

This study is recruiting. It focuses on ADHD and currently lists participation information in Switzerland.

In Switzerland
ADHDOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Stéphanie Baggio
Condition
ADHD
Other study type icon
RecruitingNCT06341517

Brain Circuitry Therapeutics for Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Switzerland.

In Switzerland
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
Indrit Begue
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06552832

CAVEAT: An Open-study Feasibility Study

This study is recruiting. It focuses on PTSD and currently lists participation information in Switzerland.

In Switzerland
PTSDBehavioralFrom 12 Months to 50 Years
Countries
Switzerland
Sponsor
University of Lausanne Hospitals
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.

Switzerland | Clinical Trials | HopeStage Research